Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 2679518, 15 pages
https://doi.org/10.1155/2017/2679518
Research Article

Immunoprofiling of Adult-Derived Human Liver Stem/Progenitor Cells: Impact of Hepatogenic Differentiation and Inflammation

1Institut de Recherche Expérimentale and Clinique (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Université Catholique de Louvain, 1200 Brussels, Belgium
2Institut de Biologie et de Médecine Moléculaires, Université Libre de Bruxelles, 6041 Gosselies, Belgium
3Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Beirut, Lebanon
4Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium

Correspondence should be addressed to Mustapha Najimi; eb.niavuolcu@imijan.ahpatsum

Received 28 September 2016; Revised 15 February 2017; Accepted 2 March 2017; Published 11 April 2017

Academic Editor: Eva Mezey

Copyright © 2017 Hoda El-Kehdy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Forbes, S. Gupta, and A. Dhawan, “Cell therapy for liver disease: from liver transplantation to cell factory,” Journal of Hepatology, vol. 62, no. 1, pp. S157–S169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Najimi, D. N. Khuu, P. A. Lysy et al., “Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes?” Cell Transplantation, vol. 16, no. 7, pp. 717–728, 2007. View at Publisher · View at Google Scholar
  3. S. Berardis, C. Lombard, J. Evraerts et al., “Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells,” PLoS One, vol. 9, no. 1, article e86137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. N. Khuu, I. Scheers, S. Ehnert et al., “In vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmacotoxicological testing,” Cell Transplantation, vol. 20, no. 2, pp. 287–302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Raicevic, M. Najar, M. Najimi et al., “Influence of inflammation on the immunological profile of adult-derived human liver mesenchymal stromal cells and stellate cells,” Cytotherapy, vol. 17, no. 2, pp. 174–185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, supplement 1, pp. D561–D568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Sakurai, “Orexin and orexin receptors,” in In Hypocretins: Integrators of Physiological Functions, de Lecea, L. and Sutcliffe, J. G., Eds., pp. 13–23, Springer, New York, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. E. Lund, R. Shariatmadari, A. Uustare et al., “The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C,” The Journal of Biological Chemistry, vol. 275, no. 40, pp. 30806–30812, 2000. View at Publisher · View at Google Scholar
  9. S. Y. Lee, H. J. Kim, and D. Choi, “Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation,” International Journal of Stem Cells, vol. 8, no. 1, pp. 36–47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. N. Khuu, O. Nyabi, C. Maerckx, E. Sokal, and M. Najimi, “Adult human liver mesenchymal stem/progenitor cells participate in mouse liver regeneration after hepatectomy,” Cell Transplantation, vol. 22, no. 8, pp. 1369–1380, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pluchino and C. Cossetti, “How stem cells speak with host immune cells in inflammatory brain diseases,” Glia, vol. 61, no. 9, pp. 1379–1401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, X. Chen, W. Cao, and Y. Shi, “Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications,” Nature Immunology, vol. 15, no. 11, pp. 1009–1016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Campioni, R. Rizzo, M. Stignani et al., “A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs,” Cytometry. Part B, Clinical Cytometry, vol. 76, no. 3, pp. 225–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. D. Vu, X. Xiao, W. Gao et al., “OX40 costimulation turns off Foxp3+ Tregs,” Blood, vol. 110, no. 7, pp. 2501–2510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nasef, N. Mathieu, A. Chapel et al., “Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G,” Transplantation, vol. 84, no. 2, pp. 231–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Li, J. Xin, L. Zhang et al., “Human hepatic progenitor cells express hematopoietic cell markers CD45 and CD109,” International Journal of Medical Sciences, vol. 11, no. 1, pp. 65–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Malhi, G. J. Gores, and J. J. Lemasters, “Apoptosis and necrosis in the liver: a tale of two deaths?” Hepatology, vol. 43, no. S1, pp. 31–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Hao, C. Li, M. Lü et al., “SDF-1/CXCR4 axis promotes MSCs to repair liver injury partially through trans-differentiation and fusion with hepatocytes,” Stem Cells International, vol. 2015, Article ID 960387, p. 10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. E. P. Chan and R. G. Wells, “Today’s hepatic stellate cells: not your father’s Sternzellen,” Hepatology, vol. 45, no. 5, pp. 1326–1327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Shen, F. Hong, V. A. Nguyen, and B. Gao, “IL-10 attenuates IFN-α-activated STAT1 in the liver: involvement of SOCS2 and SOCS3,” FEBS Letters, vol. 480, no. 2–3, pp. 132–136, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Bouhlal, R. Nyga, F. Cartier et al., “Molecular and functional characterisation of hepatic slam CD229 and ITS implication in the development of hepatocellular carcinoma,” Gut, vol. 60, Supplement 1, pp. A226–A227, 2011. View at Publisher · View at Google Scholar
  22. P. B. Patil, M. Joshi, V. K. Kuna et al., “CD271 identifies functional human hepatic stellate cells, which localize in peri-sinusoidal and portal areas in liver after partial hepatectomy,” Cytotherapy, vol. 16, no. 7, pp. 990–999, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. I. A. Malik, I. Stange, G. Martius et al., “Role of PECAM-1 in radiation-induced liver inflammation,” Journal of Cellular and Molecular Medicine, vol. 19, no. 10, pp. 2441–2452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Wang, B. Qi, P. Chen et al., “CD58 expression of liver tissue in patients with chronic hepatitis B virus infection,” Chinese Medical Journal, vol. 121, no. 6, pp. 557–560, 2008. View at Google Scholar
  25. P. F. Lalor, P. Shields, A. Grant, and D. H. Adams, “Recruitment of lymphocytes to the human liver,” Immunology and Cell Biology, vol. 80, no. 1, pp. 52–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Sers, G. Riethmüller, and J. P. Johnson, “MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread,” Cancer Research, vol. 54, no. 21, pp. 5689–5694, 1994. View at Google Scholar
  27. G. G. M. Pinkse, M. P. Voorhoeve, M. Noteborn, O. T. Terpstra, J. A. Bruijn, and E. De Heer, “Hepatocyte survival depends on beta1-integrin-mediated attachment of hepatocytes to hepatic extracellular matrix,” Liver International, vol. 24, no. 3, pp. 218–226, 2004. View at Publisher · View at Google Scholar
  28. W. Yu, J. Wang, L. Ma et al., “CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT,” Oncology Reports, vol. 32, no. 2, pp. 677–683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kimura, M. Nagaki, K. Kakimi et al., “Critical role of CD44 in hepatotoxin-mediated liver injury,” Journal of Hepatology, vol. 48, no. 6, pp. 952–961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Luo, K. Vanderkerken, L. Bouwens et al., “The role of adhesion molecules in the recruitment of hepatic natural killer cells (pit cells) in rat liver,” Hepatology, vol. 24, no. 6, pp. 1475–1480, 1996. View at Publisher · View at Google Scholar
  31. N. A. Essani, M. L. Bajt, A. Farhood, S. L. Vonderfecht, and H. Jaeschke, “Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock,” Journal of Immunology, vol. 158, no. 12, pp. 5941–5948, 1997. View at Google Scholar
  32. Z. Tian, Y. Chen, and B. Gao, “Natural killer cells in liver disease,” Hepatology, vol. 57, no. 4, pp. 1654–1662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. M. Gorczynski, “CD200:CD200R-mediated regulation of immunity,” ISRN Immunology, vol. 2012, Article ID 682168, pp. 1–18, 2012. View at Publisher · View at Google Scholar
  34. A. R. Mistry and C. A. O’Callaghan, “Regulation of ligands for the activating receptor NKG2D,” Immunology, vol. 121, no. 4, pp. 439–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Wiendl, M. Mitsdoerffer, D. Schneider et al., “Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies,” The FASEB Journal, vol. 17, no. 13, pp. 1892–1894, 2003. View at Publisher · View at Google Scholar
  36. M. Pietilä, S. Lehtonen, E. Tuovinen et al., “CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells,” PLoS One, vol. 7, no. 2, article e31671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Najar, G. Raicevic, F. Jebbawi et al., “Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes,” Immunology Letters, vol. 146, no. 1–2, pp. 50–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Delorme, J. Ringe, N. Gallay et al., “Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells,” Hematop Stem Cells, vol. 111, no. 5, pp. 2631–2635, 2008. View at Publisher · View at Google Scholar
  39. H. J. Jin, S. K. Park, W. Oh, Y. S. Yang, S. W. Kim, and S. J. Choi, “Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells,” Biochemical and Biophysical Research Communications, vol. 381, no. 4, pp. 676–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Suchting, P. Heal, K. Tahtis, L. M. Stewart, and R. Bicknell, “Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration,” The FASEB Journal, vol. 19, no. 1, pp. 121–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Zhao, A. R. Anand, and R. K. Ganju, “Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia,” Journal of Immunology, vol. 192, no. 1, pp. 385–393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Mardilovich, S. L. Pankratz, and L. M. Shaw, “Expression and function of the insulin receptor substrate proteins in cancer,” Cell Communication and Signaling: CCS, vol. 7, no. 1, p. 14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. I. Inoue, T. Ishida, N. Tsukamoto et al., “Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling,” Experimental Cell Research, vol. 254, no. 1, pp. 14–24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. G. J. Liu, R. J. Middleton, W. W. Kam et al., “Functional gains in energy and cell metabolism after TSPO gene insertion,” Cell Cycle, vol. 19, no. 5, pp. 436–447, 2017. View at Publisher · View at Google Scholar
  45. P. Gut, “Targeting mitochondrial energy metabolism with TSPO ligands,” Biochemical Society Transactions, vol. 43, no. 4, pp. 537–542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. L. N. Tu, A. H. Zhao, M. Hussein, D. M. Stocco, and V. Selvaraj, “Translocator protein (TSPO) affects mitochondrial fatty acid oxidation in steroidogenic cells,” Endocrinology, vol. 157, no. 3, pp. 1110–11121, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. M. M. Faraldo and M. A. Glukhova, “Regulating the regulator: Numb acts upstream of p53 to control mammary stem and progenitor cell,” The Journal of Cell Biology, vol. 211, no. 4, pp. 737–739, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. H. R. Siddique, D. E. Feldman, C. L. Chen, V. Punj, H. Tokumitsu, and K. Machida, “NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer,” Hepatology, vol. 62, no. 5, pp. 1466–1479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Liu, C. Sato, M. Cerletti, and A. Wagers, “Notch signaling in the regulation of stem cell self-renewal and differentiation,” Current Topics in Developmental Biology, vol. 92, pp. 367–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Kandachar and F. Roegiers, “Endocytosis and control of Notch signaling,” Current Opinion in Cell Biology, vol. 24, no. 4, pp. 534–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. McGill and C. J. McGlade, “Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain,” The Journal of Biological Chemistry, vol. 278, no. 25, pp. 23196–23203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Couturier, K. Mazouni, and F. Schweisguth, “Inhibition of Notch recycling by Numb: relevance and mechanism(s),” Cell Cycle, vol. 12, no. 11, pp. 1647–1648, 2013. View at Publisher · View at Google Scholar · View at Scopus